Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2026-01-03 @ 6:47 PM
Study NCT ID:
NCT03542461
Status:
UNKNOWN
Last Update Posted:
2022-10-03
First Post:
2018-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)
Sponsor:
Gruppo Oncologico Italiano di Ricerca Clinica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-05
First Submit QC Date:
None
Study First Post Date:
2018-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-30
Last Update Post Date:
2022-10-03
Last Update Post Date Type:
ACTUAL